Remote Assessment of Parkinson’s Disease Patients Amidst the COVID-19 Lockdown in Mexico

The COVID-19 pandemic introduced unprecedented challenges in managing patients with Parkinson’s disease (PD) due to disruptions in healthcare services and the need for social distancing. Understanding the effects of COVID-19 on PD symptoms is crucial for optimizing patient care. We conducted a compr...

Full description

Bibliographic Details
Main Authors: Rodrigo León-García, Emmanuel Ortega-Robles, Oscar Arias-Carrión
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/13/7/1114
_version_ 1797590018275934208
author Rodrigo León-García
Emmanuel Ortega-Robles
Oscar Arias-Carrión
author_facet Rodrigo León-García
Emmanuel Ortega-Robles
Oscar Arias-Carrión
author_sort Rodrigo León-García
collection DOAJ
description The COVID-19 pandemic introduced unprecedented challenges in managing patients with Parkinson’s disease (PD) due to disruptions in healthcare services and the need for social distancing. Understanding the effects of COVID-19 on PD symptoms is crucial for optimizing patient care. We conducted a comprehensive analysis of the data obtained during the period of COVID-19 lockdown, comparing it with analogous timeframes in 2018 and 2019. Our objective was to examine the influence of this unique circumstance on both motor and non-motor symptoms in patients with PD. Telemedicine was employed to assess symptoms using the Movement Disorder Society-sponsored Unified Parkinson’s Disease Rating Scale (MDS-UPDRS). Our findings revealed a notable worsening of symptoms, evidenced by a significant increase in the total MDS-UPDRS score. Specifically, there was an increase in Part III scores, reflecting changes in motor function. However, no differences were observed in Parts I or II, which pertain to non-motor symptoms. Additionally, patient satisfaction and the feasibility of telemedicine consultations were high, highlighting the efficacy of this alternative approach during the pandemic. The COVID-19 pandemic had a discernible impact on PD symptoms, with a significant worsening of motor symptoms observed during the lockdown period. Telemedicine was a valuable tool for remote assessment and follow-up, ensuring continuity of care for individuals with PD in the face of pandemic-related challenges.
first_indexed 2024-03-11T01:14:23Z
format Article
id doaj.art-30b9adcdac734f24a00e4ca10af217a2
institution Directory Open Access Journal
issn 2076-3425
language English
last_indexed 2024-03-11T01:14:23Z
publishDate 2023-07-01
publisher MDPI AG
record_format Article
series Brain Sciences
spelling doaj.art-30b9adcdac734f24a00e4ca10af217a22023-11-18T18:35:34ZengMDPI AGBrain Sciences2076-34252023-07-01137111410.3390/brainsci13071114Remote Assessment of Parkinson’s Disease Patients Amidst the COVID-19 Lockdown in MexicoRodrigo León-García0Emmanuel Ortega-Robles1Oscar Arias-Carrión2Unidad de Trastornos del Movimiento y Sueño, Hospital General Dr. Manuel Gea González, Calzada de Tlalpan 4800, Mexico City 14080, MexicoUnidad de Trastornos del Movimiento y Sueño, Hospital General Dr. Manuel Gea González, Calzada de Tlalpan 4800, Mexico City 14080, MexicoUnidad de Trastornos del Movimiento y Sueño, Hospital General Dr. Manuel Gea González, Calzada de Tlalpan 4800, Mexico City 14080, MexicoThe COVID-19 pandemic introduced unprecedented challenges in managing patients with Parkinson’s disease (PD) due to disruptions in healthcare services and the need for social distancing. Understanding the effects of COVID-19 on PD symptoms is crucial for optimizing patient care. We conducted a comprehensive analysis of the data obtained during the period of COVID-19 lockdown, comparing it with analogous timeframes in 2018 and 2019. Our objective was to examine the influence of this unique circumstance on both motor and non-motor symptoms in patients with PD. Telemedicine was employed to assess symptoms using the Movement Disorder Society-sponsored Unified Parkinson’s Disease Rating Scale (MDS-UPDRS). Our findings revealed a notable worsening of symptoms, evidenced by a significant increase in the total MDS-UPDRS score. Specifically, there was an increase in Part III scores, reflecting changes in motor function. However, no differences were observed in Parts I or II, which pertain to non-motor symptoms. Additionally, patient satisfaction and the feasibility of telemedicine consultations were high, highlighting the efficacy of this alternative approach during the pandemic. The COVID-19 pandemic had a discernible impact on PD symptoms, with a significant worsening of motor symptoms observed during the lockdown period. Telemedicine was a valuable tool for remote assessment and follow-up, ensuring continuity of care for individuals with PD in the face of pandemic-related challenges.https://www.mdpi.com/2076-3425/13/7/1114COVID-19Parkinson’s diseasemotor symptomsnon-motor symptomstelemedicine
spellingShingle Rodrigo León-García
Emmanuel Ortega-Robles
Oscar Arias-Carrión
Remote Assessment of Parkinson’s Disease Patients Amidst the COVID-19 Lockdown in Mexico
Brain Sciences
COVID-19
Parkinson’s disease
motor symptoms
non-motor symptoms
telemedicine
title Remote Assessment of Parkinson’s Disease Patients Amidst the COVID-19 Lockdown in Mexico
title_full Remote Assessment of Parkinson’s Disease Patients Amidst the COVID-19 Lockdown in Mexico
title_fullStr Remote Assessment of Parkinson’s Disease Patients Amidst the COVID-19 Lockdown in Mexico
title_full_unstemmed Remote Assessment of Parkinson’s Disease Patients Amidst the COVID-19 Lockdown in Mexico
title_short Remote Assessment of Parkinson’s Disease Patients Amidst the COVID-19 Lockdown in Mexico
title_sort remote assessment of parkinson s disease patients amidst the covid 19 lockdown in mexico
topic COVID-19
Parkinson’s disease
motor symptoms
non-motor symptoms
telemedicine
url https://www.mdpi.com/2076-3425/13/7/1114
work_keys_str_mv AT rodrigoleongarcia remoteassessmentofparkinsonsdiseasepatientsamidstthecovid19lockdowninmexico
AT emmanuelortegarobles remoteassessmentofparkinsonsdiseasepatientsamidstthecovid19lockdowninmexico
AT oscarariascarrion remoteassessmentofparkinsonsdiseasepatientsamidstthecovid19lockdowninmexico